Kane Biotech Inc. (KNE.V)
CAD 0.1
(0.0%)
CAD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 148.98 Thousand | 2.66 Million | 1.6 Million | 1.34 Million | 1.69 Million | 506.27 Thousand |
| Cost of Revenue | 39.51 Thousand | 1.25 Million | 1.03 Million | 814.71 Thousand | 1.08 Million | 390.8 Thousand |
| Gross Profit | 109.47 Thousand | 1.41 Million | 568.44 Thousand | 526.85 Thousand | 609.91 Thousand | 115.47 Thousand |
| Operating Expenses | 3.46 Million | 4.77 Million | 5.45 Million | 4.75 Million | 4.2 Million | 3.29 Million |
| Selling, General and Administrative Expenses | 2.41 Million | 3.72 Million | 4.07 Million | 3.42 Million | 2.65 Million | 2.37 Million |
| Research and Development Expenses | 1.28 Million | 1.05 Million | 1.37 Million | 1.32 Million | 1.54 Million | 922.52 Thousand |
| Other Expenses | -232.85 Thousand | 254.89 Thousand | 323.79 Thousand | 460.05 Thousand | 108.62 Thousand | - |
| Cost and Expenses | 3.5 Million | 6.03 Million | 6.49 Million | 5.56 Million | 5.28 Million | 3.68 Million |
| Operating Income | -3.35 Million | -3.36 Million | -4.88 Million | -4.22 Million | -3.59 Million | -3.17 Million |
| Interest Expense | 1.21 Million | 822.21 Thousand | 416.05 Thousand | 121.55 Thousand | 141.67 Thousand | 89.77 Thousand |
| Income Tax Expense | - | 1.14 Million | 494.5 Thousand | 452.31 Thousand | 250.29 Thousand | 89.77 Thousand |
| Earnings before Tax | -4.56 Million | -3.82 Million | -4.84 Million | -3.84 Million | -960.17 Thousand | -3.26 Million |
| Net Income | -5.03 Million | -3.88 Million | -4.6 Million | -3.71 Million | -960.17 Thousand | -3.26 Million |
| Earnings Per Share Basic | -0.04 | -0.03 | -0.04 | -0.03 | -0.01 | -0.04 |
| Earnings Per Share Diluted | -0.04 | -0.03 | -0.04 | -0.03 | -0.01 | -0.04 |
| Weighted Average Shares Outstanding | 140.26 Million | 120.7 Million | 112.6 Million | 107.54 Million | 82.3 Million | 80.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 127.11 Million | 120.7 Million | 112.6 Million | 107.54 Million | 82.3 Million | 80.11 Million |
| Gross Margin | 0.73 | 0.53 | 0.35 | 0.39 | 0.36 | 0.23 |
| EBIT Margin | -21.71 | -1.03 | -2.64 | -2.72 | -2.02 | -6.12 |
| Profit Margin | -33.79 | -1.46 | -2.86 | -2.77 | -0.57 | -6.44 |
| EBITDA | -3.23 Million | -2.94 Million | -4.24 Million | -3.64 Million | -764.08 Thousand | -3.09 Million |
| Earnings Before Tax Margin | -22.54 | -1.26 | -3.04 | -3.15 | -2.12 | -6.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 620.43 Thousand | 51.88 Thousand | -633.06 Thousand | 148.98 Thousand | 717.85 Thousand | 657.31 Thousand |
| Cost of Revenue | 259.94 Thousand | 65.94 Thousand | 375.58 Thousand | 278.1 Thousand | 402.58 Thousand | 326.8 Thousand |
| Gross Profit | 360.49 Thousand | -14.06 Thousand | -1 Million | -129.12 Thousand | 315.26 Thousand | 330.5 Thousand |
| Operating Expenses | 1.46 Million | 1.21 Million | 23.1 Thousand | 3.69 Million | 1.51 Million | 866.22 Thousand |
| Selling, General and Administrative Expenses | 978.47 Thousand | 747.23 Thousand | 353.99 Thousand | - | 1.23 Million | 814.34 Thousand |
| Research and Development Expenses | 484.92 Thousand | 469.56 Thousand | 474.62 Thousand | - | 277.4 Thousand | 60.32 Thousand |
| Other Expenses | -57.19 Thousand | - | -805.5 Thousand | - | - | - |
| Cost and Expenses | 1.72 Million | 1.28 Million | 398.69 Thousand | 3.97 Million | 1.91 Million | 866.22 Thousand |
| Operating Income | -1.1 Million | -1.23 Million | -1.03 Million | -3.82 Million | -1.19 Million | -535.72 Thousand |
| Interest Expense | 100.76 Thousand | 317.51 Thousand | - | 1.21 Million | 277.23 Thousand | 431.18 Thousand |
| Income Tax Expense | -10.41 Million | -97.96 Thousand | 264.61 Thousand | 471.75 Thousand | 210.06 Thousand | 967.9 Thousand |
| Earnings before Tax | -1.21 Million | -1.49 Million | -1.32 Million | -4.56 Million | -1.44 Million | -967.9 Thousand |
| Net Income | 9.18 Million | -1.39 Million | -1.58 Million | -5.03 Million | -1.37 Million | -967.9 Thousand |
| Earnings Per Share Basic | 0.07 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | 0.07 | -0.01 | -0.01 | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 132.35 Million | 131.84 Million | 136.05 Million | 127.11 Million | 126.79 Million | 124.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 132.35 Million | 131.84 Million | 129.48 Million | 127.11 Million | 126.79 Million | 124.93 Million |
| Gross Margin | 0.58 | -0.27 | 1.59 | -0.87 | 0.44 | 0.50 |
| EBIT Margin | -1.69 | -22.68 | 1.73 | - | -1.56 | -0.82 |
| Profit Margin | 14.80 | -26.90 | 2.50 | -33.79 | -1.92 | -1.47 |
| EBITDA | -1.04 Million | -1.17 Million | -1.09 Million | - | -1.11 Million | -535.72 Thousand |
| Earnings Before Tax Margin | -1.78 | -23.72 | 1.63 | -25.66 | -1.67 | -0.82 |
ZZZ
2283
000669
LBTYB
SMTK
PEXNY